Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary

被引:13
|
作者
Gattringer, R
Sauermann, R
Lagler, H
Stich, K
Buxbaum, A
Graninger, W
Georgopoulos, A
机构
[1] Univ Vienna, Vienna Gen Hosp, Dept Internal Med 1, Div Infect Dis & Chemotherapy, A-1090 Vienna, Austria
[2] Univ Vienna, Vienna Gen Hosp, Dept Clin Pharmacol, A-1090 Vienna, Austria
[3] Univ Vienna, Vienna Gen Hosp, Dept Internal Med 4, Div Pulm, A-1090 Vienna, Austria
关键词
Streptococcus pyogenes; susceptibility; macrolide resistance; Austria; Hungary;
D O I
10.1016/j.ijantimicag.2004.01.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A total of 341 clinical isolates of Streptococcus pyogenes from Vienna, Austria and three Hungarian cities were tested for susceptibility to four macrolides and 12 other antibiotics. All isolates were fully susceptible to penicillin and the other beta-lactams tested. A high level of tetracycline resistance was found in Austria (26.7%) and in Hungary (30.5%). The rate of resistance to erythromycin, clarithromycin and azithromycin was 4.7% in Vienna and 3.7% in the Hungarian communities. In both countries, the MIC90 values of erythromycin and clarithromycin were 0.12 mg/L and the MIC90 of josamycin was 0.5 mg/L. The M phenotype of resistance conferred by the mefA genes was predominant (n = 9) among the macrolide-resistant isolates (n = 14). (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:290 / 293
页数:4
相关论文
共 50 条
  • [1] Prevalence of Macrolide Resistance in Streptococcus pyogenes Collected in Serbia
    Pavlovic, Ljiljana
    Grego, Edita
    Sipetic-Grujicic, Sandra
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2010, 63 (04) : 275 - 276
  • [2] Antimicrobial susceptibility and analysis of macrolide resistance genes in Streptococcus pneumoniae isolated in Hamadan
    Mosleh, Mohammad Najafi
    Gharibi, Marzieh
    Alikhani, Mohammad Yousef
    Saidijam, Massoud
    Vakhshiteh, Faezeh
    [J]. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2014, 17 (08) : 595 - 599
  • [3] Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes
    Cascone, C
    Santagati, M
    Noviello, S
    Iannelli, F
    Esposito, S
    Pozzi, G
    Stefani, S
    [J]. MICROBIAL DRUG RESISTANCE, 2002, 8 (02) : 129 - 132
  • [4] Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil
    d'Oliveira, REC
    Barros, RR
    Mendonça, CRV
    Teixeira, LM
    Castro, ACD
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2003, 9 (01): : 87 - 91
  • [5] Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus pyogenes in Japan
    Tanaka, Yuhei
    Gotoh, Kenji
    Teramachi, Mariko
    Ishimoto, Kazuhisa
    Tsumura, Naoki
    Shindou, Shizuo
    Yamashita, Yushiro
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (11) : 727 - 732
  • [6] Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes
    Gagliotti, C
    Nobilio, L
    Milandri, M
    Moro, ML
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (08) : 1153 - 1156
  • [7] Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin
    Betriu, C
    Culebras, E
    Redondo, M
    Rodríguez-Avial, I
    Gómez, M
    Boloix, A
    Picazo, JJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 436 - U11
  • [8] Low macrolide resistance in Streptococcus pyogenes in Southern Argentina
    Rubinstein, G
    Amoroso, AM
    Bavdaz, B
    Blazquez, N
    Gutkind, GO
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (05) : 450 - 452
  • [9] Macrolide Resistance in Streptococcus pyogenes: A Marker of an Overuse of Macrolides
    Korppi, Matti
    [J]. PEDIATRIC PULMONOLOGY, 2009, 44 (12) : 1246 - 1247
  • [10] Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin -: Reply
    Griffiths, PD
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03)